ClearStar to Sponsor Free Webinar with CCG About Drug and Alcohol Testing in the Transportation Industry

Written By ESR News Blog Editor Thomas Ahearn ClearStar – a leading provider of Human Capital Integrity℠ technology-based services – is sponsoring a free webinar about “Drug & Alcohol Testing in the Transportation Industry” that will feature Bill Current and Rick Tennant of the Current Consulting Group, LLC (CCG), which provides expert consulting in all…

USDOT Proposes Adding Oral Fluid Testing to Transportation Industry Drug and Alcohol Testing Programs

Written By ESR News Blog Editor Thomas Ahearn On February 27, 2022, the U.S. Department of Transportation (USDOT) issued a proposal in the Federal Register on “Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs” to add oral fluid testing to the existing urine drug testing for…

FMCSA Drug and Alcohol Clearinghouse Identifies Nearly 8,000 Positive Substance Abuse Tests of Commercial Drivers

Written By ESR News Blog Editor Thomas Ahearn On February 21, 2020, the Federal Motor Carrier Safety Administration (FMCSA) released data gathered from its Commercial Driver’s License Drug and Alcohol Clearinghouse and the information showed that the Clearinghouse had detected and identified nearly 8,000 positive substance abuse tests of commercial drivers since it became operational…

FMCSA-Regulated Employers Readying for CDL Drug and Alcohol Clearinghouse

Written By ESR News Blog Editor Thomas Ahearn In October of 2019, the Federal Motor Carrier Safety Administration (FMCSA) – an administration within the U.S. Department of Transportation (DOT) responsible for regulating and providing safety oversight of commercial motor vehicles (CMVs) – opened registration for the Congressionally-mandated FMCSA Commercial Driver’s License (CDL) Drug and Alcohol…

Opioid Crisis in America Will Lead to More Advanced Drug Testing for Opiates by Employers in 2018

Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, U.S. President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed executive agencies “to fight the opioid crisis” during a speech at the White House. The growing awareness of an opioid crisis in America by employers…

DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic

Written By ESR News Blog Editor Thomas Ahearn The U.S. Department of Transportation (DOT) has issued a final rule in the Federal Register that adds four semi-synthetic opioids – hydrocodone, oxycodone, hydromorphone, and oxymorphone – to its drug testing panel for DOT regulated industries, adds methylenedioxyamphetamine (MDA) as an initial test analyte, and removes the testing…